• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library

    Eugia Pharma Fails EDQM Inspection

    EMA

    FDA Issues Form 483 to Eugia Pharma Specialities Limited

    FDA

    Enforcement Report - Week of June 25, 2025

    FDA

    Enforcement Report - Week of May 7, 2025.pdf

    FDA

    Enforcement Report - Week of April 23, 2025

    FDA

    Enforcement Report - Week of January 15, 2025

    FDA

    Eugia Pharma on Health Canada Inspection List

    HEALTH CANADA

    Eugia Pharma Specialities Receives FDA Warning Letter

    FDA

    Enforcement Report for Week of August 7, 2024

    FDA

    Enforcement Report - Week of June 26, 2024

    FDA

    FDA Issues Form 483 to Eugia Pharma Specialities

    FDA

    Enforcement Report - Week of April 17, 2024

    FDA

    FDA Issues Form 483 to Eugia Steriles Private Limited

    FDA

    Eugia US LLC (f/k/a AuroMedics Pharma LLC) Issues Voluntary Nationwide Recall of Methocarbamol Injection Due to Presence of White Particles

    FDA

    Enforcement Report - Week of March 27, 2024

    FDA

    FDA Issues Form 483 to Eugia SEZ Private Limited

    FDA

    Enforcement Report - Week of March 13, 2024

    FDA

    FDA Issues Form 483 to Eugia Pharma Specialities Limited

    FDA

    FDA Issues Form 483 to Eugia US Manufacturing LLC

    FDA

    Enforcement Report - Week of October 11, 2023

    FDA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.